B
BEKHealth
Developed a family of R&D solutions that increases the efficiency and performance of research operations
About BEKHealth
BEKHealth, founded in 2016 by Jason Baumgartner, provides a specialized software-as-a-service (SaaS) platform for the clinical research industry. The company's creation was spurred by Baumgartner's extensive experience in healthcare, including roles in genomics and consulting for major biopharmaceutical companies, where he identified a critical inefficiency in how patients were matched to clinical trials. He observed the highly manual and time-consuming processes at medical centers, which inspired him to develop a technology-driven solution to a significant industry problem.
The company's core offering is an AI-powered platform designed to streamline and accelerate clinical trial processes for research organizations, pharmaceutical companies, and contract research organizations (CROs). The business generates revenue through its integrated software suite that addresses several key areas of clinical research. This includes the BEKTRANSLATE tool for standardizing EMR data, BEK GALILEO for assessing trial feasibility, and BEK AUTORECRUITER for automating patient screening. The platform's main function is to process vast amounts of both structured and unstructured data from electronic medical records (EMRs), enabling it to identify eligible patient candidates with high precision. This capability allows clients to assess population feasibility for studies, optimize trial protocols, and significantly speed up patient recruitment.
A key feature of BEKHealth's technology is its ability to extract and analyze data from physician notes and other unstructured sources within EMRs, which traditionally are difficult to parse. This allows the system to capture up to three times more trial criteria compared to conventional methods, leading to a more comprehensive and accurate matching of patients to studies. By automating what is typically a manual chart review process, the platform helps research sites increase enrollment rates, expand their trial portfolios, and improve the diversity of trial participants. The company reports that its solution can lead to finding ten times more qualified patients and doubling the speed of enrollment. To date, BEKHealth has secured $15.7 million in funding over four rounds from investors including Hatteras Venture Partners, Boston Millennia Partners, and Excelerate Health Ventures.
Source: Dealroom company dataNews
Open roles
BEKHealth in the Raleigh ecosystem
The BEKHealth office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
- BPBoston Millennia Partners
Connecticut Innovations
Change Healthcare
Martin Ventures
Excelerate Health Ventures
Series B and later3 investors entered at this stage
RTI International
Hatteras Venture Partners
WakeMed
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about BEKHealth on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BEKHealth on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

